Get the Stockscreener App
0.375
0.92%
0.002
Envveno Medical Corporation stock is traded at $0.375, with a volume of 34,466.
It is up +0.92% in the last 24 hours and up +6.46% over the past month.
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
See More
Previous Close:
$0.373
Open:
$0.375
24h Volume:
34,466
Relative Volume:
0.07
Market Cap:
$7.64M
Revenue:
-
Net Income/Loss:
$-24.05M
P/E Ratio:
-0.1744
EPS:
-2.15
Net Cash Flow:
$-17.78M
1W Performance:
+12.78%
1M Performance:
+6.46%
6M Performance:
-90.57%
1Y Performance:
-89.06%
1-Day Range:
$0.375
$0.3798
1-Week Range:
$0.3104
$0.3816
52-Week Range:
$0.3011
$5.62
Envveno Medical Corporation Stock (NVNO) Company Profile
Name
Envveno Medical Corporation
Sector
Industry
Phone
949-261-2900
Address
70 DOPPLER, IRVINE
Compare NVNO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NVNO
Envveno Medical Corporation
|
0.3781 | 7.54M | 0 | -24.05M | -17.78M | -2.15 |
|
ABT
Abbott Laboratories
|
128.65 | 219.88B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.42 | 141.54B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
356.74 | 133.39B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.80 | 124.82B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.72 | 48.84B | 5.88B | 1.34B | 799.60M | 2.3489 |
Envveno Medical Corporation Stock (NVNO) Latest News
enVVeno Medical (NASDAQ:NVNO) to Participate in a Live Virtual Investor CEO Connect Segment - Times Herald-Record
enVVeno Receives Unfavorable Appeal Decision from the FDA for the VenoValve - Fall River Herald News
enVVeno Medical Shares Crash After FDA Reaffirms VenoValve Rejection - MSN
Is enVVeno Medical Corporation (5HJ) stock positioned for secular growth2025 Sector Review & Technical Pattern Based Buy Signals - Улправда
NVNBW SEC FilingsEnvveno Med Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Can enVVeno Medical Corporation stock deliver sustainable ROE2025 Market Outlook & Verified High Yield Trade Plans - ulpravda.ru
Will enVVeno Medical Corporation stock pay special dividends2025 Top Decliners & Capital Efficient Trading Techniques - Улправда
enVVeno Medical Reports Third Quarter 2025 Financial Results and Provides Corporate Update - Shelby Star
How enVVeno Medical Corporation stock reacts to inflationary pressuresWeekly Risk Summary & Advanced Technical Signal Analysis - Улправда
How enVVeno Medical Corporation stock benefits from global expansion2025 Bull vs Bear & Daily Stock Momentum Reports - Улправда
Will enVVeno Medical Corporation stock sustain high P E ratios2025 Trading Volume Trends & Technical Entry and Exit Tips - Улправда
Can enVVeno Medical Corporation stock hit record highs againAnalyst Downgrade & Real-Time Market Trend Scan - Улправда
Why enVVeno Medical Corporation stock is rated strong buyJuly 2025 PostEarnings & Stepwise Trade Signal Guides - Улправда
Will enVVeno Medical Corporation stock outperform Nasdaq index2025 Trading Volume Trends & High Accuracy Investment Entry Signals - Улправда
[Form 4] enVVeno Medical Corp Insider Trading Activity - Stock Titan
enVVeno Medical (NVNO) CTO surrenders 50,000 performance RSUs - Stock Titan
Is enVVeno Medical Corporation stock ready for breakoutPortfolio Value Summary & Free Verified High Yield Trade Plans - Улправда
Why enVVeno Medical Corporation stock remains on buy listsRecession Risk & Real-Time Volume Analysis - Улправда
Will enVVeno Medical Corporation stock benefit from infrastructure spending2025 AllTime Highs & Accurate Buy Signal Notifications - Улправда
enVVeno Medical (NVNO) details director stock option award of 135,883 - Stock Titan
enVVeno Medical Corp (NVNO) director receives 135,883 stock options - Stock Titan
enVVeno Medical Corp (NVNO) director awarded 135,883 options on December 11, 2025 - Stock Titan
enVVeno Medical Corp (NVNO) director gets 135,883 stock options vesting in 2026 - Stock Titan
EnVVeno Medical shareholders approve reverse stock split, reject equity plan - Investing.com India
enVVeno Medical (NVNO) director sells 4,900 shares under 10b5-1 plan - Stock Titan
enVVeno Medical Holds Annual Stockholders Meeting - TipRanks
[8-K] enVVeno Medical Corp Reports Material Event | NVNO SEC FilingForm 8-K - Stock Titan
What drives enVVeno Medical Corporation stock pricePrice Action Analysis & Low Cost Wealth Plans - earlytimes.in
A History of Outperforming Analyst Forecasts and Beating the Odds: enVVeno Medical Corporation (NVNO) - setenews.com
enVVeno Medical Shares Continue to Face Downward Pressure - AD HOC NEWS
Is enVVeno Medical Corporation (5HJ) stock a good hedge against inflation2025 Retail Activity & Fast Gain Swing Trade Alerts - Newser
How enVVeno Medical Corporation (5HJ) stock reacts to stronger dollarJuly 2025 Action & Target Return Focused Picks - Newser
Will enVVeno Medical Corporation (5HJ) stock profit from fiscal stimulus2025 Bull vs Bear & Risk Adjusted Buy and Sell Alerts - Newser
Why enVVeno Medical Corporation stock is favored by top institutionsEntry Point & Stock Market Timing Techniques - Newser
Is enVVeno Medical Corporation (5HJ) stock undervalued by metricsMarket Sentiment Report & Consistent Income Trade Recommendations - Newser
How enVVeno Medical Corporation stock compares to industry benchmarks2025 Market Trends & Fast Entry Momentum Trade Alerts - Newser
Is enVVeno Medical Corporation (5HJ) stock resilient in recession scenariosTrade Entry Report & AI Forecasted Entry/Exit Points - Newser
Can enVVeno Medical Corporation (5HJ) stock deliver double digit returnsWeekly Stock Summary & Free Expert Verified Stock Movement Alerts - Newser
Is enVVeno Medical Corporation (5HJ) stock worth holding before Fed meetingTrade Exit Summary & Weekly Breakout Stock Alerts - Newser
enVVeno Medical (NASDAQ: NVNO) adds reverse stock split vote to 2025 meeting - Stock Titan
Midday Stock Roundup: Tilly’s, indie Semiconductor Up - Orange County Business Journal
The growth track for enVVeno Medical Corporation (NVNO) has changed recently - setenews.com
Why analysts maintain buy rating on enVVeno Medical Corporation (5HJ) stockJuly 2025 Chart Watch & Low Drawdown Investment Ideas - Newser
Published on: 2025-12-02 03:25:08 - Newser
Envveno Medical Corporation Stock (NVNO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
0.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):